Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 56 Lung Neoplasms 48 Leukemia, Myeloid, Acute 44 Breast Neoplasms 37 Carcinoma, Non-Small-Cell Lung 36 Myelodysplastic Syndromes 27 Pancreatic Neoplasms 24 Leukemia, Lymphocytic, Chronic, B-Cell 24 Multiple Myeloma 23 Colorectal Neoplasms 23 Carcinoma, Renal Cell 22 Neoplasm Metastasis 20 Melanoma 19 Glioblastoma 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Ovarian Neoplasms 17 Lymphoma, Large B-Cell, Diffuse 17 Brain Neoplasms 16 Triple Negative Breast Neoplasms 14 Squamous Cell Carcinoma of Head and Neck 12 Carcinoma, Hepatocellular 12 Lymphoma, Mantle-Cell 11 Lymphoma, B-Cell 11 Leukemia, Myelomonocytic, Chronic 11 Fallopian Tube Neoplasms 11 Rectal Neoplasms 10 Myeloproliferative Disorders 10 Lymphoma, Follicular 10 Colonic Neoplasms 10 Hematopoietic and Lymphatic System Neoplasm 9

Interventions

Taxes 1 Specimen Handling 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pancreatic Cystic Neoplasm × Specimen Handling × Clear all

NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡